CDX2 as a Prognostic Biomarker in Stage II and Stage III Colon Cancer

During the past decade, disease-free survival among patients with stage III colon cancer has increased significantly owing to the introduction of new adjuvant chemotherapy regimens. This therapeutic success, however, has not translated into longer disease-free survival among patients with earlier…

from #Medicine-SfakianakisAlexandros via o.lakala70 on Inoreader http://ift.tt/1S6h4zO
via IFTTT

from #Med Blogs by Alexandros G.Sfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/1Pjvq0E
via IFTTT

from #Med Blogs by Alexandros G.Sfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/1S6DnoP
via IFTTT